Humana cuts 2025 GAAP EPS guidance to $12.26 as third-quarter profit falls
Humana reported third-quarter 2025 GAAP EPS of $1.62, down from $3.98 a year earlier, and adjusted EPS of $3.24, down from $4.16, while consolidated GAAP revenue rose to $32.6 billion from $29.4 billion. The company lowered its full-year 2025 GAAP EPS guidance to approximately $12.26 from approximately $13.77 but kept its adjusted EPS guidance at approximately $17.00, which matters to shareholders because the GAAP cut reflects charges and fair value adjustments excluded from the adjusted figure.
Key points
- 3Q25 GAAP EPS of $1.62 vs $3.98 in 3Q24; adjusted EPS of $3.24 vs $4.16
- 3Q25 GAAP pretax income of $134 million vs $651 million in 3Q24
- FY 2025 GAAP EPS guidance cut to approximately $12.26 from approximately $13.77; adjusted guidance affirmed at approximately $17.00
- 3Q25 Insurance segment benefit ratio of 91.1 percent, in line with prior expectation of 'just above 91 percent'
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.